201 related articles for article (PubMed ID: 11179452)
1. The transcription factor Fos-related antigen 1 is induced by thiazolidinediones during differentiation of 3T3-L1 cells.
Albrektsen T; Fleckner J
Mol Pharmacol; 2001 Mar; 59(3):567-75. PubMed ID: 11179452
[TBL] [Abstract][Full Text] [Related]
2. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
[TBL] [Abstract][Full Text] [Related]
3. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.
Takamura T; Nohara E; Nagai Y; Kobayashi K
Eur J Pharmacol; 2001 Jun; 422(1-3):23-9. PubMed ID: 11430909
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes.
Camp HS; Whitton AL; Tafuri SR
FEBS Lett; 1999 Mar; 447(2-3):186-90. PubMed ID: 10214942
[TBL] [Abstract][Full Text] [Related]
5. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene.
Frohnert BI; Hui TY; Bernlohr DA
J Biol Chem; 1999 Feb; 274(7):3970-7. PubMed ID: 9933587
[TBL] [Abstract][Full Text] [Related]
6. Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes.
Sugawara A; Takeuchi K; Uruno A; Ikeda Y; Arima S; Sato K; Kudo M; Taniyama Y; Ito S
Hypertens Res; 2001 May; 24(3):229-33. PubMed ID: 11409645
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
Tafuri SR
Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen CB; Lazar MA
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5793-6. PubMed ID: 8650171
[TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
10. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
Wang M; Wise SC; Leff T; Su TZ
Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes.
Kurebayashi S; Hirose T; Miyashita Y; Kasayama S; Kishimoto T
Diabetes; 1997 Dec; 46(12):2115-8. PubMed ID: 9392507
[TBL] [Abstract][Full Text] [Related]
13. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
Shimaya A; Kurosaki E; Shioduka K; Nakano R; Shibasaki M; Shikama H
Horm Metab Res; 1998 Sep; 30(9):543-8. PubMed ID: 9808320
[TBL] [Abstract][Full Text] [Related]
14. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
Chen NG; Han X
Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
[TBL] [Abstract][Full Text] [Related]
16. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB.
Ruan H; Pownall HJ; Lodish HF
J Biol Chem; 2003 Jul; 278(30):28181-92. PubMed ID: 12732648
[TBL] [Abstract][Full Text] [Related]
18. A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes.
Glorian M; Duplus E; Beale EG; Scott DK; Granner DK; Forest C
Biochimie; 2001 Oct; 83(10):933-43. PubMed ID: 11728630
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi P; Xu M; Spiegelman BM
J Clin Invest; 1997 Oct; 100(7):1863-9. PubMed ID: 9312188
[TBL] [Abstract][Full Text] [Related]
20. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
